These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34470083)

  • 21. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
    Fletcher EJR; Moon LDF; Duty S
    BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.
    Aumann TD
    J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
    Cragg S; Rice ME; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment.
    Haddadi R; Eyvari-Brooshghalan S; Nayebi AM; Sabahi M; Ahmadi SA
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2427-2437. PubMed ID: 32715318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson's disease.
    Slézia A; Hegedüs P; Rusina E; Lengyel K; Solari N; Kaszas A; Balázsfi D; Botzanowski B; Acerbo E; Missey F; Williamson A; Hangya B
    Sci Rep; 2023 Nov; 13(1):19478. PubMed ID: 37945922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons.
    Castelli MP; Spiga S; Perra A; Madeddu C; Mulas G; Ennas MG; Gessa GL
    Neuroscience; 2016 Sep; 332():130-9. PubMed ID: 27365174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease.
    Drui G; Carnicella S; Carcenac C; Favier M; Bertrand A; Boulet S; Savasta M
    Mol Psychiatry; 2014 Mar; 19(3):358-67. PubMed ID: 23399912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VGluT2 Expression in Dopamine Neurons Contributes to Postlesional Striatal Reinnervation.
    Kouwenhoven WM; Fortin G; Penttinen AM; Florence C; Delignat-Lavaud B; Bourque MJ; Trimbuch T; Luppi MP; Salvail-Lacoste A; Legault P; Poulin JF; Rosenmund C; Awatramani R; Trudeau LÉ
    J Neurosci; 2020 Oct; 40(43):8262-8275. PubMed ID: 32928885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
    J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cocaine Selectively Reorganizes Excitatory Inputs to Substantia Nigra Pars Compacta Dopamine Neurons.
    Beaudoin GMJ; Gomez JA; Perkins J; Bland JL; Petko AK; Paladini CA
    J Neurosci; 2018 Jan; 38(5):1151-1159. PubMed ID: 29263240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins.
    Pereira Luppi M; Azcorra M; Caronia-Brown G; Poulin JF; Gaertner Z; Gatica S; Moreno-Ramos OA; Nouri N; Dubois M; Ma YC; Ramakrishnan C; Fenno L; Kim YS; Deisseroth K; Cicchetti F; Dombeck DA; Awatramani R
    Cell Rep; 2021 Nov; 37(6):109975. PubMed ID: 34758317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion.
    Ilango A; Kesner AJ; Keller KL; Stuber GD; Bonci A; Ikemoto S
    J Neurosci; 2014 Jan; 34(3):817-22. PubMed ID: 24431440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
    Liang CL; Wang TT; Luby-Phelps K; German DC
    Exp Neurol; 2007 Feb; 203(2):370-80. PubMed ID: 17010972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vivo Assessment of Cell Death and Nigrostriatal Pathway Integrity Following Continuous Expression of C3 Transferase.
    Gupta RV; Santiago-Lopez AJ; Berglund K; Gross RE; Gutekunst CN
    Neuroscience; 2020 Aug; 442():183-192. PubMed ID: 32652176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.
    Steinkellner T; Zell V; Farino ZJ; Sonders MS; Villeneuve M; Freyberg RJ; Przedborski S; Lu W; Freyberg Z; Hnasko TS
    J Clin Invest; 2018 Feb; 128(2):774-788. PubMed ID: 29337309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.
    Pacelli C; Giguère N; Bourque MJ; Lévesque M; Slack RS; Trudeau LÉ
    Curr Biol; 2015 Sep; 25(18):2349-60. PubMed ID: 26320949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration.
    Baydyuk M; Nguyen MT; Xu B
    Exp Neurol; 2011 Mar; 228(1):118-25. PubMed ID: 21192928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A partial lesion of the substantia nigra pars compacta and retrorubral field decreases the harmaline-induced glutamate release in the rat cerebellum.
    Gołembiowska K; Berghauzen-Maciejewska K; Górska A; Kamińska K; Ossowska K
    Brain Res; 2013 Nov; 1537():303-11. PubMed ID: 24012623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.